71 results on '"Lawson, John A."'
Search Results
2. A first-principles study of the phase transitions in ultrahigh temperature shape memory alloy RuNb
3. Accelerated long-term forgetting in children with temporal lobe epilepsy: A timescale investigation of material specificity and executive skills
4. Detecting molecular subtypes from multi-omics datasets using SUMO
5. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders
6. Accelerated long-term forgetting in children with genetic generalized epilepsy: The temporal trajectory and contribution of executive skills
7. Facial emotion perception and social competence in children (8 to 16 years old) with genetic generalized epilepsy and temporal lobe epilepsy
8. Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells
9. Properties of minimal mutation-infinite quivers
10. Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome
11. Frequency and predictors of psychological distress after a diagnosis of epilepsy: A community-based study
12. Management Strategies for CLN2 Disease
13. Bioactive products formed in humans from fish oils
14. A statistical approach to control porosity in silica-doped alumina supports
15. Ten-Year Single-Center Experience of the Ketogenic Diet: Factors Influencing Efficacy, Tolerability, and Compliance
16. Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
17. Prostaglandin D2 Inhibits Wound-Induced Hair Follicle Neogenesis through the Receptor, Gpr44
18. Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Angiogenesis Proteins in Familial Adenomatous Polyposis
19. Hematopoietic prostaglandin D synthase (HPGDS): A high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer
20. Deletion of Microsomal Prostaglandin E Synthase-1 Does Not Alter Ozone-Induced Airway Hyper-Responsiveness
21. Novel Eicosapentaenoic Acid-derived F3-isoprostanes as Biomarkers of Lipid Peroxidation
22. Tetranor PGDM, an Abundant Urinary Metabolite Reflects Biosynthesis of Prostaglandin D2 in Mice and Humans
23. Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid
24. Identification of a Novel Prostaglandin Reductase Reveals the Involvement of Prostaglandin E2 Catabolism in Regulation of Peroxisome Proliferator-activated Receptor γ Activation
25. Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins
26. Agonist and Antagonist Effects of 15 R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils
27. Oxidized derivatives of ω-3 fatty acids: identification of IPF3α-VI in human urine
28. Quality of Life of Children With Benign Rolandic Epilepsy
29. Marked Interindividual Variability in the Response to Selective Inhibitors of Cyclooxygenase-2
30. 12/15-Lipoxygenase Is Increased in Alzheimer's Disease: Possible Involvement in Brain Oxidative Stress
31. Cold-Induced Browning of Inguinal White Adipose Tissue Is Independent of Adipose Tissue Cyclooxygenase-2
32. Validation of the Quality of Life in Childhood Epilepsy Questionnaire in American epilepsy patients
33. Predicting the functional state of protein kinases using interpretable graph neural networks
34. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders
35. Prothrombinase Acceleration by Oxidatively Damaged Phospholipids
36. Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F2α-III, a Metabolite of Isoprostane F2α-III and an Oxidation Product of γ-Linolenic Acid
37. Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
38. Basal Transepidermal Water Loss is Increased in Platelet-Type 12-Lipoxygenase Deficient Mice
39. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor
40. LUMIPULSE G® CSF AD BIOMARKER CONCORDANCE TO PET IN THE KBASE COHORT
41. A UNIFIED PRE-ANALYTICAL PROTOCOL FOR HANDLING OF CSF SAMPLES BEFORE ANALYSES OF AD BIOMARKER LEVELS
42. LUMIPULSE® G TOTAL TAU TO β-AMYLOID 1-42 RATIO CUT-POINT DETERMINATION FOR AMYLOID ELIGIBILITY SCREENING
43. LUMIPULSE® G TOTAL TAU: KEY PERFORMANCES OF A FULLY AUTOMATED CHEMILUMINESCENT IMMUNOASSAY
44. PERFORMANCE OVERVIEW OF THE INNOTEST B-AMYLOID(1-40)
45. Expert opinion on the management of CLN2 disease
46. The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer’s disease: For the coalition against major diseases
47. Lack of genetic association of either A2M or LRP with sporadic Alzheimer's disease
48. Association of the TNF-α C-850T polymorphism with vascular dementia in Northern Ireland
49. F2 and E2 isoprostanes are ligands for peroxisome proliferator-activated receptors α and γ
50. Pyrazolo[1,5-a]pyrimidines: Receptor binding and anxiolytic behavioral studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.